Altrinsic Global Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ambev
ABEV
|
+$61.2M |
| 2 |
Baidu
BIDU
|
+$22.9M |
| 3 |
SLB Ltd
SLB
|
+$18.5M |
| 4 |
XL
XL Group Ltd.
XL
|
+$18.1M |
| 5 |
Molson Coors Class B
TAP
|
+$17.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Televisa
TV
|
+$53.8M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$45M |
| 3 |
Aon
AON
|
+$33.2M |
| 4 |
Willis Towers Watson
WTW
|
+$33M |
| 5 |
Loews
L
|
+$26.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.95% |
| 2 | Communication Services | 18.41% |
| 3 | Healthcare | 11.34% |
| 4 | Consumer Staples | 8.74% |
| 5 | Industrials | 7.05% |
Similar funds
Altrinsic Global Advisors's Q2 2017 Portfolio in Review
As of Q2 2017, Altrinsic Global Advisors held 86 positions worth $2.77B, down 6% from $2.94B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Altrinsic Global Advisors withdrew a net $317M in Q2 2017, closing 2 positions and reducing 52 holdings. Its most notable exit was Air Methods Corp, an estimated $15.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 33% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, Altrinsic Global Advisors opened a new position in Alexion Pharmaceuticals worth $3.65M.
- Altrinsic Global Advisors's largest Q2 2017 buy was Alexion Pharmaceuticals: 30,000 shares worth $3.65M.
- Altrinsic Global Advisors added most to Ambev in Q2 2017, an estimated $61.2M increase.
- Altrinsic Global Advisors's biggest Q2 2017 reduction was Televisa, cutting an estimated $53.8M.
- Altrinsic Global Advisors fully exited Air Methods Corp in Q2 2017, selling an estimated $15.2M.
- Altrinsic Global Advisors's ten largest holdings make up 49% of its $2.77B portfolio in Q2 2017.
- Altrinsic Global Advisors opened 2 new positions and closed 2 in Q2 2017.
- Altrinsic Global Advisors's portfolio value fell 6% quarter-over-quarter to $2.77B.
Based on Altrinsic Global Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.